Rizatriptan Tablet, Film Coated
Product Images NDC 33342-088

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 33342-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rizatriptan 10mg Bottle 200s Pack

Text panel for Rizatriptan Benzoate Tablets, USP 10 mg from Macleods Pharmaceuticals Limited, providing dosage strength details, storage conditions (20° to 25°C with permitted excursions), pharmacist dispensing instructions, manufacturing locations, and a barcode. It notes the tablet contains 14.53 mg Rizatriptan Benzoate USP equivalent to 10 mg Rizatriptan and refers to usual adult dosing in prescribing information.*

FDA Label Image

Rizatriptan 10mg Bottle 30s Pack

Packaging label for Rizatriptan Benzoate Tablets USP 10 mg by Macleods Pharmaceuticals Limited. The label indicates the tablet strength as 10 mg, includes storage instructions, and states pharmacist dispensing information. The package contains 30 film-coated oral tablets. Manufactured for Macleods Pharma USA, Inc., Princeton, NJ, and by Macleods Pharmaceuticals Ltd., Himachal Pradesh, India.*

FDA Label Image

Rizatriptan 5 mg 18s 3x6s

Packaging label for Rizatriptan Benzoate Tablets USP 5 mg film-coated tablets by Macleods Pharmaceuticals Limited. The label indicates an 18-tablet package (3 x 6 unit-dose tablets) with instructions for opening the blister pack, lot and expiration date fields, and storage conditions. The label also includes NDC 33342-087-41 and mentions the product is for oral use and prescription only.*

FDA Label Image

Rizatriptan 5 mg 18s 6x3s

Packaging label for Rizatriptan Benzoate Tablets, USP 5 mg film-coated oral tablets. The label indicates a package containing 18 tablets (6 x 3 unit-dose tablets), manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc. The label also includes instructions for opening the blister pack and storage conditions, along with a barcode and dosage details.*

FDA Label Image

Rizatriptan 5mg Bottle 200s Pack

This label is for Rizatriptan Benzoate Tablets, USP 5 mg film-coated oral tablets, packaged by Macleods Pharmaceuticals Limited. The label states the package contains 200 tablets and includes storage instructions at controlled room temperature. It also cites Macleods Pharma USA, Inc. as the manufacturer for the U.S. and Macleods Pharmaceuticals Ltd. in India. The label highlights dispensing patient information to pharmacists.*

FDA Label Image

Rizatriptan 5mg Bottle 30s Pack

Label for Rizatriptan Benzoate Tablets USP 5 mg, film-coated oral tablets supplied in a bottle of 30 tablets. The label shows the product name, strength, and manufacturer as Macleods Pharmaceuticals Limited. It includes storage instructions and a note to dispense the patient information leaflet with the drug product.*

FDA Label Image

Rizatriptan Fct 10 mg 12s 2x6s

Packaging label for Rizatriptan Benzoate Tablets, USP 10 mg, film-coated oral tablets in a child-resistant unit-dose blister pack containing 12 tablets (2 x 6). Manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, with storage instructions and instructions for opening the blister pack visible on the label.*

FDA Label Image

Rizatriptan Fct 10 mg 12s 4x3s

Rizatriptan Benzoate Tablets, USP 10 mg film-coated oral tablets packaging label by Macleods Pharmaceuticals Limited. The unit-dose blister pack contains 12 tablets (4 x 3) and includes instructions for opening the blister pack. The label specifies storage and dosage information and shows the NDC 33342-088-50, manufactured for Macleods Pharma USA, Inc., Princeton, NJ.*

FDA Label Image

Rizatriptan Fct 10 mg 18s 3x6s

Rizatriptan Benzoate Tablets USP 10 mg film-coated tablet carton from Macleods Pharmaceuticals Limited. The carton indicates the product is for oral use, contains 18 tablets (3 x 6 unit-dose tablets), and instructs pharmacists to dispense the patient information leaflet. Storage and dose instructions are partially visible as well as manufacturer details and blister pack opening instructions.*

FDA Label Image

Rizatriptan Fct 10 mg 18s 6x3s

Rizatriptan Benzoate Tablets USP 10 mg film-coated oral tablets packaging label from Macleods Pharmaceuticals Limited. The label includes dosage strength, package size of 18 tablets (6 x 3 unit-dose tablets), storage instructions, child-resistant unit-dose packaging details, and instructions for opening the blister pack. The product is manufactured in India for Macleods Pharma USA.*

FDA Label Image

Rizatriptan Fct 5 mg 12s 2x6s

Packaging label for Rizatriptan Benzoate Tablets, USP 5 mg by Macleods Pharmaceuticals Limited. The label indicates a unit-dose blister pack containing 12 tablets (2 x 6). It includes storage instructions, dosage form as film-coated tablets, and is manufactured for Macleods Pharma USA, Inc. The label also shows instructions for opening the blister pack and various barcodes and regulatory information.*

FDA Label Image

Rizatriptan Fct 5 mg 12s 4x3s

Rizatriptan Benzoate Tablets USP 5 mg film-coated oral tablets packaging label from Macleods Pharmaceuticals Limited, distributed by Macleods Pharma USA. The unit-dose package contains 12 tablets (4 x 3), includes instructions for opening the blister pack, and storage information. The label notes the equivalent content of Rizatriptan Benzoate per tablet and states the package is child-resistant.*

FDA Label Image

Rizatriptan Fct Figure 5

A line graph comparing the percent response over time (hours post stage 2 dose) for Rizatriptan Benzoate Orally Disintegrating Tablets and placebo. The graph shows two lines with error bars representing 95% confidence intervals, indicating response percentages at 0.5, 1.0, 1.5, and 2.0 hours after dosing.*

FDA Label Image

Rizatriptan Figure One

A line chart showing the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate Tablets 5 mg, 10 mg, and placebo. The x-axis represents hours post-dose (0 to 2 hours) and the y-axis shows the estimated probability of response (0% to 100%). Rizatriptan 10 mg shows the highest response probability, followed by 5 mg, both exceeding placebo.*

FDA Label Image

Rizatriptan Figure Two

A line graph showing the estimated probability of remediation or rescue over 24 hours post-dose for Rizatriptan Benzoate Tablets 5 mg, 10 mg, and placebo. The x-axis represents hours post-dose, and the y-axis shows probability from 0% to 100%. The graph compares the response rates of two doses of Rizatriptan with placebo.*

FDA Label Image

Rizatriptan Structure One

Chemical structure of Rizatriptan, the active ingredient shown as part of the molecular diagram. The structure includes a triazole ring, an indole moiety, an alkyl amine side chain, and a benzoic acid component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.